IGI Executive Director Jennifer Doudna and her research collaborator, Emmanuelle Charpentier, have been named 2015 Thomson Reuters Citation Laureates. Both are being acknowledged for their development of the CRISPR-Cas9 method of precision genome editing which enables researchers to identify potential treatments for genetic diseases.

This distinction is derived from an examination of the citation data within the Web of Science, highlighting the significance of research contributions in the eyes of the scientific community (based upon the number of times researchers cite published papers) and identifying the most influential researchers in chemistry, physics, physiology or medicine, and economics who are likely winners of the Nobel Prize now or in the future.